UK: Lawsuit Seeks $2bn Over Claims Apple Pay Harmed Consumers

Startupnews
A lawsuit is seeking $2 billion from Apple, alleging that Apple Pay’s control limited competition and harmed consumers.

Summary

A $2 billion lawsuit has been filed in the UK against Apple, spearheaded by Fairer Finance founder James Daley. The lawsuit claims that Apple’s dominance over Apple Pay has stifled competition within the banking system, ultimately leading to increased costs that were passed on to consumers. This legal action argues that Apple’s control created an anticompetitive environment, negatively impacting the broader financial landscape. The claim is based on reporting by The Guardian.

(Source:Startupnews)

WBRZ

$5M lawsuit claims Disney's California theme parks illegally collect facial recognition data

CP24 Toronto

Judge approves class action lawsuit launched by Quebec TV personality

The Bradenton Times

Maryland reaches $4.1M settlement with homebuilder in sediment pollution case

Tekedia

Tether Invests on LemFi to Accelerate Stablecoin Settlement Flow in Africa and Asia

Headtopics

President Trump, Family, and Businesses Shielded from Pending Tax Audits as Part of DOJ Settlement

Bitcoin News

Evernorth Highlights XRP’s ‘Actual Story’ Beyond JPMorgan Settlement Attention

Punch

SEC fixes June 1 for T+1 settlement cycle transition

Firstpost

Why is Trump’s new IRS settlement triggering allegations of ‘self-dealing’?

Syracuse Ny Local News

Government to permanently drop tax claims against Trump family as part of lawsuit settlement

USA TODAY

Disney sued over facial recognition at California theme parks

New York Post

Disneyland targeted in class-action lawsuit claiming new program is violating guests' privacy

Bangor Daily News

Journalists sue tech giants over 'stolen' voices for AI training

The Mercury News

Disneyland hit with $5 million lawsuit over use of facial recognition technology

Devdiscourse

UPDATE 4-Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

The Japan Times

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury